An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer
IL-2/anti-IL-2 complexes have been proposed to curtail the severe adverse effects associated with IL-2 immunotherapy. Here, the authors, by integrating unmutated human IL-2 in the antigen binding groove of an anti-IL-2 monoclonal antibody, generate a CD122-biased fusion protein that prevents binding...
Guardado en:
Autores principales: | Dilara Sahin, Natalia Arenas-Ramirez, Matthias Rath, Ufuk Karakus, Monika Hümbelin, Merel van Gogh, Lubor Borsig, Onur Boyman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bccae141645e49d6828a1fe5efe66a25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms
por: Cristina Stefanescu, et al.
Publicado: (2021) -
Nanotechnology-enhanced immunotherapy for metastatic cancer
por: Peisen Zhang, et al.
Publicado: (2021) -
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
por: Hong-fen Guo, et al.
Publicado: (2021) -
Improving cancer immunotherapy by targeting IL-1
por: Zhilan Xiao, et al.
Publicado: (2021) -
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
por: David J. Benjamin, et al.
Publicado: (2021)